Zoetis Inc. (ZTS) suffered a pre-market plunge of 7.41% on Thursday, as the animal healthcare company's 2025 profit and revenue forecasts fell short of Wall Street estimates.
Zoetis projected adjusted earnings per share for 2025 to be between $6.00 and $6.10, missing analysts' average estimate of $6.29. The company also guided for full-year revenue in the range of $9.23 billion to $9.38 billion, lower than the consensus estimate of $9.57 billion. The disappointing outlook was partly attributed to the impact of a stronger dollar and the divestiture of certain product portfolios.
Despite the weak guidance, Zoetis reported better-than-expected results for the fourth quarter. Adjusted earnings of $1.40 per share exceeded expectations of $1.34, while revenue rose 5% year-over-year to $2.32 billion, slightly above estimates. However, the market's focus appears to be on the company's muted outlook for 2025, leading to the steep pre-market decline.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。